A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment

Brittany Vasae Burdick, Bryon Adinoff

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Current treatments for addiction are frequently ineffective. Hallucinogenic therapy has been indicated as helpful for a range of substance use disorders, yet this approach remains understudied and publicly unavailable. It is nonetheless a promising treatment, which has significant, long-term beneficial effects with single doses and a profile characterized by general safety, low toxicity, and non-addictiveness. However, pharmacological interventions, such as hallucinogens, should not be offered if the same effects (e.g. psychological insights/mystical experiences) and outcomes (e.g. decreased drug use) could be achieved absent pharmacological intervention. To date, there have been no clinical comparisons of drug-induced altered states with non-drug-induced states for addiction treatment. We propose and then outline a clinical trial to address this gap in knowledge. The proposed design would evaluate abstinence outcomes in a population of prescription opioid abusers after exposure to one of three conditions: a drug-induced altered state using psilocybin, a non-drug-induced altered state via hyperventilation (Holotropic Breathwork), and an active placebo with niacin. The outcomes of such a study would reveal important differences in therapeutic potential by discriminating hallucinogen-dependent effects from those psychological effects resulting from altered states.

Original languageEnglish (US)
Pages (from-to)291-297
Number of pages7
JournalAmerican Journal of Drug and Alcohol Abuse
Volume39
Issue number5
DOIs
StatePublished - Sep 2013

Fingerprint

Hallucinogens
Psilocybin
Pharmaceutical Preparations
Pharmacology
Psychology
Therapeutics
Hyperventilation
Niacin
Opioid Analgesics
Substance-Related Disorders
Prescriptions
Placebos
Clinical Trials
Safety
Population

Keywords

  • Addiction
  • Drug abuse
  • Hallucinogens
  • Psilocybin
  • Review

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment. / Burdick, Brittany Vasae; Adinoff, Bryon.

In: American Journal of Drug and Alcohol Abuse, Vol. 39, No. 5, 09.2013, p. 291-297.

Research output: Contribution to journalArticle

Burdick, Brittany Vasae ; Adinoff, Bryon. / A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment. In: American Journal of Drug and Alcohol Abuse. 2013 ; Vol. 39, No. 5. pp. 291-297.
@article{1c0576dbf7cc4cbb9bf98083a277478c,
title = "A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment",
abstract = "Current treatments for addiction are frequently ineffective. Hallucinogenic therapy has been indicated as helpful for a range of substance use disorders, yet this approach remains understudied and publicly unavailable. It is nonetheless a promising treatment, which has significant, long-term beneficial effects with single doses and a profile characterized by general safety, low toxicity, and non-addictiveness. However, pharmacological interventions, such as hallucinogens, should not be offered if the same effects (e.g. psychological insights/mystical experiences) and outcomes (e.g. decreased drug use) could be achieved absent pharmacological intervention. To date, there have been no clinical comparisons of drug-induced altered states with non-drug-induced states for addiction treatment. We propose and then outline a clinical trial to address this gap in knowledge. The proposed design would evaluate abstinence outcomes in a population of prescription opioid abusers after exposure to one of three conditions: a drug-induced altered state using psilocybin, a non-drug-induced altered state via hyperventilation (Holotropic Breathwork), and an active placebo with niacin. The outcomes of such a study would reveal important differences in therapeutic potential by discriminating hallucinogen-dependent effects from those psychological effects resulting from altered states.",
keywords = "Addiction, Drug abuse, Hallucinogens, Psilocybin, Review",
author = "Burdick, {Brittany Vasae} and Bryon Adinoff",
year = "2013",
month = "9",
doi = "10.3109/00952990.2013.811513",
language = "English (US)",
volume = "39",
pages = "291--297",
journal = "American Journal of Drug and Alcohol Abuse",
issn = "0095-2990",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment

AU - Burdick, Brittany Vasae

AU - Adinoff, Bryon

PY - 2013/9

Y1 - 2013/9

N2 - Current treatments for addiction are frequently ineffective. Hallucinogenic therapy has been indicated as helpful for a range of substance use disorders, yet this approach remains understudied and publicly unavailable. It is nonetheless a promising treatment, which has significant, long-term beneficial effects with single doses and a profile characterized by general safety, low toxicity, and non-addictiveness. However, pharmacological interventions, such as hallucinogens, should not be offered if the same effects (e.g. psychological insights/mystical experiences) and outcomes (e.g. decreased drug use) could be achieved absent pharmacological intervention. To date, there have been no clinical comparisons of drug-induced altered states with non-drug-induced states for addiction treatment. We propose and then outline a clinical trial to address this gap in knowledge. The proposed design would evaluate abstinence outcomes in a population of prescription opioid abusers after exposure to one of three conditions: a drug-induced altered state using psilocybin, a non-drug-induced altered state via hyperventilation (Holotropic Breathwork), and an active placebo with niacin. The outcomes of such a study would reveal important differences in therapeutic potential by discriminating hallucinogen-dependent effects from those psychological effects resulting from altered states.

AB - Current treatments for addiction are frequently ineffective. Hallucinogenic therapy has been indicated as helpful for a range of substance use disorders, yet this approach remains understudied and publicly unavailable. It is nonetheless a promising treatment, which has significant, long-term beneficial effects with single doses and a profile characterized by general safety, low toxicity, and non-addictiveness. However, pharmacological interventions, such as hallucinogens, should not be offered if the same effects (e.g. psychological insights/mystical experiences) and outcomes (e.g. decreased drug use) could be achieved absent pharmacological intervention. To date, there have been no clinical comparisons of drug-induced altered states with non-drug-induced states for addiction treatment. We propose and then outline a clinical trial to address this gap in knowledge. The proposed design would evaluate abstinence outcomes in a population of prescription opioid abusers after exposure to one of three conditions: a drug-induced altered state using psilocybin, a non-drug-induced altered state via hyperventilation (Holotropic Breathwork), and an active placebo with niacin. The outcomes of such a study would reveal important differences in therapeutic potential by discriminating hallucinogen-dependent effects from those psychological effects resulting from altered states.

KW - Addiction

KW - Drug abuse

KW - Hallucinogens

KW - Psilocybin

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=84883010169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883010169&partnerID=8YFLogxK

U2 - 10.3109/00952990.2013.811513

DO - 10.3109/00952990.2013.811513

M3 - Article

C2 - 23968172

AN - SCOPUS:84883010169

VL - 39

SP - 291

EP - 297

JO - American Journal of Drug and Alcohol Abuse

JF - American Journal of Drug and Alcohol Abuse

SN - 0095-2990

IS - 5

ER -